Indicators

Markets:

News

Latest News about MRTX

Recent news which mentions MRTX

< Previous 1 2 3 4 5 6 Next >

Stocks That Hit 52-Week Lows On Friday

May 27, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

May 27, 2022

Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting

May 27, 2022

Mid-Morning Market Update: Markets Open Higher; US Goods Trade Deficit Narrows In April

May 27, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

May 27, 2022

Even this pessimistic Bank of America strategist says the bear-market bandwagon has room to charge ahead

May 27, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

May 26, 2022

Expert Ratings for Mirati Therapeutics

May 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

May 20, 2022

Mirati Therapeutics's Return On Capital Employed Overview

May 20, 2022

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

May 20, 2022

Analyst Ratings for Mirati Therapeutics

May 05, 2022

Mirati Therapeutics: Q1 Earnings Insights

May 04, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

Earnings Preview For Mirati Therapeutics

May 03, 2022

Stocks That Hit 52-Week Lows On Thursday

April 21, 2022

7 Potential Biotech Stocks Buyout Targets in 2022

April 21, 2022

Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies

April 13, 2022

Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why

March 09, 2022

Where Mirati Therapeutics Stands With Analysts

March 01, 2022

Earnings Scheduled For February 28, 2022

February 28, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

Preview: Mirati Therapeutics's Earnings

February 25, 2022

56 Biggest Movers From Yesterday

February 17, 2022

Why Mirati Therapeutics Stock Is Plunging Today

February 16, 2022

Stocks That Hit 52-Week Lows On Wednesday

February 16, 2022

40 Stocks Moving In Wednesday's Mid-Day Session

February 16, 2022

Mirati Therapeutics' Adagrasib Application Under FDA Review For Lung Cancer Setting

February 16, 2022

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

February 16, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

February 16, 2022

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.